Vetmedin Pimobendan Chewable 2.5 Mg Np
226 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
226
Total Reports
13
Deaths Reported
580.0%
Death Rate
Active Ingredients
Vetmedin Pimobendan Chewable 2.5 Mg Np
Administration Routes
OralUnknownTopical
Species Affected
Dog 226
Most Affected Breeds
Crossbred Canine/dog 108
Spaniel - King Charles Cavalier 53
Dog (unknown) 11
Griffon - Brussels 6
Terrier - Yorkshire 6
Dog (other) 5
Sheepdog - Shetland 5
Chihuahua 4
Whippet 3
Spaniel - Cocker American 3
Most Reported Reactions
Vomiting 38
Cough 32
Lethargy (see also Central nervous system depression in Neurological) 21
Diarrhoea 16
Panting 11
Decreased appetite 11
Loose stool 9
Not eating 8
Death by euthanasia 8
Anxiety 6
Pulmonary hypertension 6
Proteinuria 5
Outcome Breakdown
Recovered/Normal
125 (55.3%)
Outcome Unknown
69 (30.5%)
Ongoing
17 (7.5%)
Euthanized
8 (3.5%)
Died
5 (2.2%)
Recovered with Sequela
2 (0.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.